Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02653196
Title A Multi-Institutional Phase II Feasibility Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Montefiore Medical Center
Indications

central nervous system cancer

Advanced Solid Tumor

Therapies

Thiotepa

Etoposide

Alemtuzumab

Palifermin

Fludarabine + Melphalan

Cyclosporine + Mycophenolate mofetil + Tacrolimus

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.